David Pass and
Adam Hameed bring decades of
business development, strategy, and industry experience to Glooko's
leadership team
PALO
ALTO, Calif., May 21, 2024
/PRNewswire/ -- Glooko, Inc., a global integrated digital health
company connecting patients, providers, biopharma and medical
partners, proudly announces the appointments of Dr. David Pass and Adam
Hameed as Presidents of Life Sciences and Connected Care,
respectively.
By establishing these new roles, Glooko is positioning itself
for continued growth and innovation in chronic condition
management. With the evolving landscape of healthcare technology
and increasing demand for personalized care, these new roles
underscore Glooko's commitment to driving advancements not only in
health systems, but also across the life sciences space,
specifically: digital companions/therapeutics, clinical research,
real-world data and device integrations.
Dr. Pass joins Glooko as President of Life Sciences with
extensive experience in pharmaceuticals, medical devices, and
healthcare technology. With over 25 years of commercial and
business leadership, his deep therapeutic experience in chronic
conditions such as Type 2 Diabetes, Obesity, and Cardiovascular
Disease, will help further accelerate Glooko's growth in Life
Sciences. Meanwhile, Mr. Hameed assumes the role of President of
Connected Care, leveraging his strong background in healthcare
technology and growth strategy. Mr. Hameed assumes a pivotal role
in advancing the Connected Care growth strategy, focusing on global
sales and account management.
"We are thrilled to welcome David and Adam as Presidents of Life
Sciences and Connected Care," said Russ
Johannesson, CEO of Glooko. "With David and Adam leading our
market facing strategies for these differentiated business units,
we are confident that their unique experience and close
collaboration will help Glooko drive significant new value for our
customers, users and partners globally."
In his previous roles, Dr. Pass served as Chief Operating
Officer and Chief Commercial Officer at Gelesis and Vice President
of Marketing at Boehringer Ingelheim (BI) for Diabetes, where he
built a multi-billion dollar franchise and led the BI alliance with
Eli Lilly & Company. Mr. Hameed brings a strong commercial
strategy background from Andros, where he served as Chief Growth
Officer, and Cricket Health (now part of Interwell Health), where
he served as Chief Development Officer. Prior to that, Mr. Hameed
held key leadership positions at Optum, where he led Payer Sales
and Account Management for OptumHealth as well as several
go-to-market teams for OptumInsight.
About Glooko
Glooko improves health outcomes of people
with chronic conditions through its personalized, intelligent,
connected care platform. Our proven technologies make lives better
by revolutionizing the connection between patients and providers,
driving patient engagement and adherence via digital therapeutics,
and accelerating the speed of clinical trials. Glooko is globally
deployed in over 30 countries and 8,000+ clinical locations. For
more information, please visit glooko.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/glooko-announces-presidents-of-life-sciences-and-connected-care-302149323.html
SOURCE Glooko, Inc.